LLY

992.23

+0.48%↑

JNJ

224.08

-0.79%↓

ABBV

205.44

-0.58%↓

UNH

367.84

+1.31%↑

AZN

185.21

+2.03%↑

LLY

992.23

+0.48%↑

JNJ

224.08

-0.79%↓

ABBV

205.44

-0.58%↓

UNH

367.84

+1.31%↑

AZN

185.21

+2.03%↑

LLY

992.23

+0.48%↑

JNJ

224.08

-0.79%↓

ABBV

205.44

-0.58%↓

UNH

367.84

+1.31%↑

AZN

185.21

+2.03%↑

LLY

992.23

+0.48%↑

JNJ

224.08

-0.79%↓

ABBV

205.44

-0.58%↓

UNH

367.84

+1.31%↑

AZN

185.21

+2.03%↑

LLY

992.23

+0.48%↑

JNJ

224.08

-0.79%↓

ABBV

205.44

-0.58%↓

UNH

367.84

+1.31%↑

AZN

185.21

+2.03%↑

Search

DaVita Inc

Open

SectorGezondheidszorg

189.54 22.93

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

154.48

Max

190.33

Belangrijke statistieken

By Trading Economics

Inkomsten

769M

1.1B

Verkoop

200M

3.6B

K/W

Sectorgemiddelde

15.778

67.147

EPS

3.4

Winstmarge

29.801

Werknemers

78,000

EBITDA

81M

718M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+22.66% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

1.9B

9.9B

Vorige openingsprijs

166.61

Vorige sluitingsprijs

189.54

Nieuwssentiment

By Acuity

82%

18%

327 / 347 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

DaVita Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

29 dec 2025, 06:30 UTC

Acquisities, Fusies, Overnames

Berkshire's Buffett Is Stepping Down. Why Little Will Change and Why That's OK. -- Barrons.com

Peer Vergelijking

Prijswijziging

DaVita Inc Prognose

Koersdoel

By TipRanks

22.66% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 189 USD  22.66%

Hoogste 220 USD

Laagste 158 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor DaVita Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Technische score

By Trading Central

142.36 / 144.275Steun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

327 / 347 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
help-icon Live chat